Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL732070 | 0.94 | TSHR (0.56) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL12828298 | 0.89 | TSHR (0.44) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL17085514 | 0.87 | TSHR (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| Cyclohexanol SCHEMBL28034283 | 0.85 | TSHR (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL733108 | 0.84 | TSHR (0.61) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL732374 | 0.83 | TSHR (0.54) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| Cyclohexanol SCHEMBL7067224 | 0.80 | SMN1; SMN2 (0.50) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| Hypochlorous Acid SCHEMBL27968375 | 0.79 | TSHR (0.59) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 | |
| SCHEMBL17450073 | 0.79 | TP53 (0.37) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL28812806 | 0.78 | TSHR (0.54) | TSHRSMN1; SMN2ALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113881025-B | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-113881025-A | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| US-8911976-B2 | Lignin-based enzyme stabilizer | FORESTRY AND FOREST PRODUCTS RESEARCH INSTITUTE (JP) | 2014-12-16 | — | — | US | claimed |
| US-7913857-B2 | Polyamide overcoated with a crosslinked epoxy resin and a hydrophilic compound, being covalently bonded to the polyamide membrane; reverse osmosis membrane; water insolubility; permselectivity | WOONGJIN CHEMICAL CO., LTD. (KR) | 2011-03-29 | — | — | US | claimed |
| EP-2140929-A1 | Selective membrane having a high fouling resistance and preparation method thereof | Woongjin Chemical Co., Ltd. (KR) | 2010-01-06 | — | — | EP | claimed |
| US-20070175821-A1 | Selective membrane having a high fouling resistance | TORAY ADVANCED MATERIALS KOREA INC, (KR) | 2007-08-02 | — | — | US | claimed |
| CN-113881025-B | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-113881025-A | Branched polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-104039862-B | Sulfide-extended epoxy resin and application of barrier coating thereof | 太阳化学公司 | 2017-12-22 | — | — | CN | disclosed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-8911976-B2 | Lignin-based enzyme stabilizer | FORESTRY AND FOREST PRODUCTS RESEARCH INSTITUTE (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20140342091-A1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATING APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2014-11-20 | — | — | US | disclosed |
| US-8889802-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2014-11-18 | — | — | US | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| CN-101309992-A | Mercaptan-hardened epoxy polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL CO (US) | 2008-11-19 | — | — | CN | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070175821-A1 | Selective membrane having a high fouling resistance | TORAY ADVANCED MATERIALS KOREA INC, (KR) | 2007-08-02 | — | — | US | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | TSHR 4571/4885SMN1; SMN2 4271/4885ALDH1A1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.